Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16433374 | 0.94 | MEN1 (0.45) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL537081 | 0.85 | SMN1; SMN2 (0.53) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Iodide SCHEMBL3733345 | 0.83 | SMN1; SMN2 (0.51) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL503460 | 0.83 | SMN1; SMN2 (0.51) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL20079455 | 0.80 | MEN1 (0.35) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL20079456 | 0.80 | MEN1 (0.42) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Iodide SCHEMBL8913347 | 0.75 | MEN1 (0.66) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Iodide SCHEMBL8915790 | 0.75 | MEN1 (0.66) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL16638796 | 0.74 | TBXAS1 (0.44) | MEN1MAPTKMT2A | |
| SCHEMBL9067248 | 0.72 | LMNA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9954162-B2 | Reactive ionic liquid, and ion-immobilized metal oxide particle, ion-immobilized elastomer, and transducer using same | SUMITOMO RIKO COMPANY LIMITED (JP) | 2018-04-24 | — | — | US | disclosed |
| US-9954162-B2 | Reactive ionic liquid, and ion-immobilized metal oxide particle, ion-immobilized elastomer, and transducer using same | SUMITOMO RIKO COMPANY LIMITED (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | SUMITOMO RIKO COMPANY LIMITED (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | SUMITOMO RIKO COMPANY LIMITED (JP) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | L1CAM, ITGA2B, AS3MT | MEN1 2216/4885APAF1 2404/4885NPC1 4317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.